Thrombopoietin Receptor Agonist


Eltrombopag desired effects:

  • Increased Platelet Production
  • Increased Megakaryocyte Maturation

Eltrombopag drug classes:

  • Thrombopoietin Receptor Agonist

Eltrombopag mechanism of action:

  • UGT1A3 Inhibitors
  • UGT2B7 Inhibitors
  • UGT1A6 Inhibitors
  • UGT1A9 Inhibitors
  • UGT1A4 Inhibitors
  • Thrombopoietin Receptor Agonists
  • Breast Cancer Resistance Protein Inhibitors
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors
  • UGT2B15 Inhibitors
  • UGT1A1 Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 2/7/2023, 10:37:49 PM